KIMBERLY BRUMFIELD: Open Payments
NPI 1972992196 · GALLIPOLIS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,848 in 68 payments from 10 companies in 2025. Trend: 2023 $893 · 2024 $902 · 2025 $1,848
Food & beverage: $1,285Speaker / faculty: $564
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $764 |
| ABBVIE INC. | 25 | $268 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $229 |
| Teva Pharmaceuticals USA, Inc. | 2 | $143 |
| Indivior Inc. | 4 | $115 |
| Vanda Pharmaceuticals Inc. | 4 | $84 |
| Braeburn Inc. | 4 | $75 |
| Alkermes, Inc. | 3 | $67 |
| Lundbeck LLC | 3 | $60 |
| Janssen Pharmaceuticals, Inc | 2 | $44 |
Products named: REXULTI, VRAYLAR, CAPLYTA, AUSTEDO XR, SUBLOCADE, FANAPT, BRIXADI, VIVITROL.
Industry payments across OH — which companies pay providers there.
